[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ojuka et al., 2012 - Google Patents

The role of CaMKII in regulating GLUT4 expression in skeletal muscle

Ojuka et al., 2012

View PDF @Full View
Document ID
1499043520432717142
Author
Ojuka E
Goyaram V
Smith J
Publication year
Publication venue
American Journal of Physiology-Endocrinology and Metabolism

External Links

Snippet

Contractile activity during physical exercise induces an increase in GLUT4 expression in skeletal muscle, helping to improve glucose transport capacity and insulin sensitivity. An important mechanism by which exercise upregulates GLUT4 is through the activation of …
Continue reading at journals.physiology.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Ojuka et al. The role of CaMKII in regulating GLUT4 expression in skeletal muscle
Mellstrom et al. Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models
Zhang et al. Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure
Flynn et al. Late‐life rapamycin treatment reverses age‐related heart dysfunction
Kalra et al. Nitric oxide provokes tumor necrosis factor-α expression in adult feline myocardium through a cGMP-dependent pathway
Bodine et al. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bassel-Duby et al. Signaling pathways in skeletal muscle remodeling
Olson et al. Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype?
Jensen et al. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction
Barry et al. What causes a broken heart—molecular insights into heart failure
Li et al. Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy
Frost et al. Regulation of muscle growth by pathogen-associated molecules
Sachan et al. Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart
Wei et al. Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface
Sung et al. A neuronal isoform of protein kinase G couples mitogen-activated protein kinase nuclear import to axotomy-induced long-term hyperexcitability in Aplysia sensory neurons
Clocchiatti et al. Beside the MEF2 axis: unconventional functions of HDAC4
Frost et al. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C2C12 myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathways
Liang et al. Mitogen-activated protein kinase–activated protein kinase 2 inhibition attenuates fibroblast invasion and severe lung fibrosis
Ji et al. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis
Lu et al. Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation
Leenders et al. Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling
Jagannath et al. The multiple roles of salt-inducible kinases in regulating physiology
Hauck et al. p21CIP1/WAF1-dependent inhibition of cardiac hypertrophy in response to Angiotensin II involves Akt/Myc and pRb signaling
CN103965342A (en) MG53 mutant, and mutation method and application thereof
Cho Molecular targeting of ERKs/RSK2 signaling in cancers